Stock Analysis
Laboratorios Farmaceuticos Rovi Full Year 2023 Earnings: Revenues In Line With Expectations
Laboratorios Farmaceuticos Rovi (BME:ROVI) Full Year 2023 Results
Key Financial Results
- Revenue: €829.5m (up 1.4% from FY 2022).
- Net income: €170.3m (down 15% from FY 2022).
- Profit margin: 21% (down from 24% in FY 2022). The decrease in margin was driven by higher expenses.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Laboratorios Farmaceuticos Rovi Meets Expectations
Revenue was in line with analyst estimates.
Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in Spain.
Performance of the Spanish Pharmaceuticals industry.
The company's shares are up 3.3% from a week ago.
Risk Analysis
We should say that we've discovered 1 warning sign for Laboratorios Farmaceuticos Rovi that you should be aware of before investing here.
Valuation is complex, but we're helping make it simple.
Find out whether Laboratorios Farmaceuticos Rovi is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BME:ROVI
Laboratorios Farmaceuticos Rovi
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally.
Excellent balance sheet and good value.